River Cities Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

SPR Therapeuticssprtherapeutics.com in 𝕏Oct 2021 · $37M

SPR is a medical device company that develops the SPRINT Peripheral Nerve Stimulation (PNS) System, a non-opioid, non-surgical, minimally invasive treatment for acute and chronic pain.

HardwareHealthtechMedical DevicesCleveland, US

Maria Bennett(President, CEO & Founder)inJosh Boggs(Executive Officer)inMark Stulz(Executive Officer)Marilyn A. Eisele(Executive Officer)Ben Austin(Chief Financial Officer)inDavid Youngberg(Chief Commercial Officer)

Co-investorsJumpstart Ventures Mutual Capital Partners NDI RC Capital Revelation Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.